The significance of luminex testing in renal transplant recipients with allograft dysfunction.

被引：0
|
作者：
Qazi, Yasir A. [1 ]
Cicciarelli, James [1 ]
Hermes, Mark [1 ]
Smogorzewski, Miroslaxv [1 ]
Koss, Michael [1 ]
Sher, Linda [1 ]
Selby, Robert R. [1 ]
机构：
[1] Keck Sch Med, USC Multiorgan Abdominal Transplantat, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
803
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [1] Sirolimus is effective as a rescue agent in pediatric renal transplant recipients with allograft dysfunction.
    Al-Akash, SI
    Al Makadma, AS
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 66 - 66
  • [2] The pathogenesis of acute allograft dysfunction in desensitized renal transplant recipients
    Singh, N.
    Sun, Q.
    Nadasdy, T.
    Adams, P.
    DiPaola, N. R.
    Pesavento, T.
    Winters, H.
    Satoskar, A.
    Yu, Z.
    Henry, M.
    Hadley, G. A.
    Pelletier, R. P.
    CLINICAL TRANSPLANTATION, 2012, 26 (04) : E402 - E411
  • [3] Increased Risk for Allograft Loss in African American Kidney Transplant Recipients After Biopsy for Chronic Allograft Dysfunction.
    Dorr, C. R.
    Wu, B.
    Guo, B.
    Guan, W.
    Schladt, D.
    Elmer, S.
    Crary, G.
    Onyeaghala, G.
    Oetting, W.
    Agarwal, G.
    Mannon, R. B.
    Jacobson, P.
    Matas, A.
    Israni, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1114 - 1115
  • [4] SAFETY OF THYMOGLOBULIN IN MINIMIZING MAINTENANCE IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS WITH RENAL DYSFUNCTION.
    Washburn, K.
    Ghobrial, R. M.
    Langnas, A. N.
    Freise, C.
    Eckhoff, D.
    Klintmalm, G.
    Sher, L.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S105 - S105
  • [5] Calcineurin inhibitor withdrawal and replacement with sirolimus in cardiac transplant recipients with renal dysfunction.
    Kushwaha, SS
    Wilson, JA
    Frantz, RP
    Rodeheffer, RJ
    Clavell, AL
    Daly, RC
    McGregor, CG
    Edwards, BS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 170 - 170
  • [6] Indirect allorecognition of MHC peptides in human renal allograft recipients with chronic graft dysfunction.
    Vella, JP
    Murphy, B
    Alexander, S
    Sayegh, MH
    Carpenter, CB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3258 - A3258
  • [7] LUMINEX CROSSMATCH FOR PRETRANSPLANT EVALUATION OF RENAL TRANSPLANT RECIPIENTS
    Lal, Vandana
    Mishra, Mahendra N.
    HUMAN IMMUNOLOGY, 2015, 76 : 39 - 39
  • [8] Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.
    Fernández-Miranda, C
    de Bustillo, EM
    Morales, JM
    Porres, A
    Gomez-Gerique, J
    Guijarro, C
    Aranda, JL
    Andrés, A
    Rodicio, JL
    Del Palacio, A
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 374 - 374
  • [9] C1q Dominant Deposits in Renal Transplant Biopsies Are Not Associated with Allograft Dysfunction.
    Babu, A.
    Williamson, S.
    Khoury, N.
    Safwan, M.
    Patel, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 892 - 892
  • [10] Is Renal Allograft Dysfunction a Risk Factor for Severe Infection in Kidney Transplant Recipients?
    Mourad, G.
    Dussol, B.
    Daugas, E.
    Joly, D.
    Juillard, L.
    Henri, P.
    Stroumza, P.
    Touam, M.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2821 - 2823
12345